Previous Page  29 / 30 Next Page
Information
Show Menu
Previous Page 29 / 30 Next Page
Page Background

Page 101

conferenceseries

.com

Volume 7

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Pharma Europe 2018

May 07-09, 2018

May 07-09, 2018 | Frankfurt, Germany

15

th

Annual European Pharma Congress

Hypoglycemic, hypolipidemic andhistological effects of ethylacetate extract of

Combretumplatypterum

leaves in alloxan induced rats

Fagbohun A B, Fred-Jaiyesimi A A, Sagamu, Nigeria Ndimele B E, Oluboba M A, James E S

and

Ibitoye S F

Olabisi Onabanjo University, Nigeria

Statement of the Problem:

Plants with medicinal properties are rich in phytochemical compounds. Some botanical

polysaccharides have important bioactive components responsible for hypoglycemic effect, while some plants are known to

have hypolipidemic activity. The purpose of this study is to determine the hypoglycemic, hypolipidemic and histological effects

of ethylacetate extract of

Combertum platypterum

leaves in alloxan induced rats.

Methodology&TheoreticalOrientation:

Sequential extractionwas carried out on the plant leaves using n-Hexane, ethylacetate

and methanol. These were concentrated to constant weights. Phytochemical screening was carried out on the crude sample of

Combretum platypterum

leaves. Diabetes was induced in the albino rats by the administration of alloxan monohydrate (150

mg/kg i.p.). The ethylacetate extract of

Combretum platypterum

at different doses of body weight were administered orally at

a single dose per day to the diabetic induced rats for a period of 13 days. The effects of the ethylacetate extract of

Combretum

platypterum

leaves and glibenclamide on blood glucose, plasma lipid and blood chemical parameters were measured in the

diabetic rats. Histological effect of the ethylacetate extract of

Combretum platypterum

leaves was also carried on the liver,

spleen, kidney and heart of the diabetic rats.

Findings:

Phytochemical screening showed the presence of flavonoids, saponins, cardiac glycosides, cyanogenetic glycosides,

tannins and alkaloids, while anthraquinones were absent. Hypoglycemic effect of the ethylacetate extract of

C. platypterum

showed a significant positive effect. Administration of glibenclamide and the ethylacetate extract of

C. platypterum

showed

significant hypolipidemic effect when compared with the reference range. This also caused reduction in total triglyceride and

total cholesterol levels. Histological result showed that

C. platypterum

has no toxic effect on the organs.

Conclusion&Significance:

The ethylacetate extract of

C. platypterum

showed both hypoglycemic and hypolipidemic activities.

Combretum platypterum

has a great potential with activities to lead to desired drug design.

ayodelefagbohun@yahoo.com

Pharmaceut Reg Affairs 2018, Volume 7

DOI: 10.4172/2167-7689-C1-031